Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: Results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial

Journal of the American College of Cardiology

Volumn 56, Issue 7, 2010, Pages 550-557

  Di Sciascio, Germano ^a   Patti, Giuseppe ^a   Pasceri, Vincenzo ^b   Gatto, Laura ^a   Colonna, Giuseppe ^c   Montinaro, Antonio ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c VITO FAZZI HOSPITAL   (Italy)

Author keywords

ACS; acute coronary syndrome; CABG; coronary artery bypass surgery; MACE; major adverse cardiac events; non ST segment elevation; NSTE; P2Y12 reaction units; PCI; percutaneous coronary intervention; PRU

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATINE KINASE MB; PURINERGIC P2Y12 RECEPTOR; TROPONIN I;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG SAFETY; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASCULAR DISEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 77955640907     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.01.067     Document Type: Article

References (30)

1. G. Patti, G. Colonna, V. Pasceri, L. Lassandro Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study Circulation 111 2005 2099 2106
2. W. Hochholzer, D. Trenk, and D. Frundi, et al. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention Circulation 111 2005 2560 2564
3. P.A. Gurbel, C.C. Cummings, C.R. Bell, A.B. Alford, A.F. Meister, and V.L. Serebruany Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial Am Heart J 145 2003 239 247
4. I. Muller, M. Seyfarth, and S. Rudiger, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93
5. S.R. Steinhubl, S. Darrah, D. Brennan, E. McErlean, P.B. Berger, and E.J. Topol Optimal duration of pretreatment with clopidogrel prior to PCI: data from the CREDO trial Circulation 108 Suppl I 2003 I1742
6. D.E. Kandzari, P.B. Berger, A. Kastrati, et al. ISAR-REACT Study Investigators Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization J Am Coll Cardiol 44 2004 2133 2136
7. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, G. Di Sciascio ARMYDA Investigators Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study Circulation 110 2004 674 678
8. G. Patti, M. Chello, and D. Candura, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 2006 1455 1461
9. G. Patti, M. Chello, and V. Pasceri, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy J Am Coll Cardiol 48 2006 1560 1566
10. G. Patti, V. Pasceri, and G. Colonna, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278
11. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention Results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of MYocardial Damage During Angioplasty-Platelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
12. D. Uettwiller-Geiger, A.H. Wu, and F.S. Apple, et al. Multicenter evaluation of an automated assay for troponin I Clin Chem 48 2002 869 876
13. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
14. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12© cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322
15. A. Malinin, A. Pokov, and M. Spergling, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12 rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study Thromb Res 119 2007 277 284
16. M.J. Price, S. Endemann, and R.R. Gollapudi, et al. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000
17. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195
18. A. Prasad, B.J. Gersh, and M.E. Bertrand, et al. Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 477 486
19. A.K. Rao, C. Pratt, and A. Berke, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
20. G.W. Stone, B.T. McLaurin, D.A. Cox, et al. ACUITY Investigators Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
21. A. Kastrati, J. Mehilli, F.J. Neumann, et al. Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pre-treatment: the ISAR-REACT 2 randomized trial JAMA 295 2006 1531 1538
22. S.R. Mehta, C.B. Granger, and J.W. Eikelboom, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial J Am Coll Cardiol 50 2007 1742 1751
23. S.V. Rao, K. O'Grady, and K.S. Pieper, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
24. P. Widimsky, Z. Motovská, and S. Simek, et al. Clopidogrel pretreatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 Eur Heart J 29 2008 1495 1503
25. R. Marcucci, A.M. Gori, and R. Paniccia, et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
26. R. Ebrahimi, C. Dyke, and R. Mehran, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 53 2009 1965 1972
27. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
28. T. Geisler, M. Kapp, and K. Göhring-Frischholz, et al. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease Heart 94 2008 743 747
29. K.A. Ault, C.P. Cannon, and J. Mitchell, et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial Thrombolysis in Myocardial Infarction J Am Coll Cardiol 33 1999 634 639
30. J.L. Anderson, C.D. Adams, and E.M. Antman, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) J Am Coll Cardiol 50 2007 e1 e157